Healthcare
Prestige Consumer Healthcare Inc.(PBH)
Live Price
Offline$46.20
+0.13% today
1Y Change
-42.22%
Window
Jun 30, 2025 โ Jun 17, 2026
- Market Cap
- $2.61B
- Revenue Growth
- +1.1%
- EPS Growth
- +2.6%
- Dividend Yield
- 0.0%
Coverage: 243 bars ยท Jun 30, 2025 โ Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Prestige Consumer Healthcare Inc. (PBH) is a Healthcare stock with a market cap of $2.61B and listed on NYSE. The stock last traded around $46.20 and down 42.2% across the available one-year price window (Jun 30, 2025 โ Jun 17, 2026). Baseline metrics include revenue growth of +1.1%, EPS growth of +2.6%, a dividend yield of 0.0%. What stands out right now is revenue +1.1%, EPS +2.6%, free cash flow +1.6% with operating margin 29.2% and ROIC 6.7%. Valuation is more restrained than many high-expectation growth names at P/E 14.1 and price/sales 2.4. Stock Foundry combines PBH price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+1.1% vs +7.6% peer median
Operating Margin
Above sector median
+29.2% vs +19.4% peer median
P/E
Below sector median
14.1 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 14, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +1.1% and EPS at +2.6%, with operating margin around 29.2%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +1.6% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 14, 2026 | โ | +1.8% | +5.0% | +4.1% |
2026 Feb 5, 2026 | -1.7% | +1.2% | +2.2% | +2.5% |
2025 Nov 6, 2025 | +10.3% | -2.3% | -2.2% | -0.9% |
Benchmark Edge
PBH vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
Relative Read
PBH trails SPY
PBH is 62.14 pts behind over the shared 1Y window.
PBH had 34.29 pts deeper max drawdown than SPY.
PBH beat SPY in 0 of 2 calendar years shown and trailed in 2.
PBH
-42.22%
Normalized return
SPY
+19.93%
S&P 500
Excess Return
-62.14 pts
Relative to SPY
PBH Max Drawdown
-43.43%
Trailing 1Y
SPY Max Drawdown
-9.13%
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for PBH and SPY.
| Year | PBH | SPY | Excess | Leader |
|---|---|---|---|---|
| 2026 | -24.63% | +6.71% | -31.34 pts | SPY |
| 2025 | -22.04% | +11.19% | -33.23 pts | SPY |
Company Overview
Prestige Consumer Healthcare Inc.
New York Stock Exchange
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
- Leadership
- Ronald Lombardi
- IPO Date
- Feb 10, 2005
- Employees
- 600
- Street Address
- 660 White Plains Road
- Mailing
- Tarrytown, NY, 10591
- Region
- Tarrytown, NY, US
- Reporting Currency
- USD
- Investor Line
- 914 524 6800
- Last Updated
- May 3, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 14.1
- EV/EBITDA
- 10.7
- Price/Sales
- 2.4
- Price/Book
- 1.4
Growth
- Revenue
- +1.1%
- EPS
- +2.6%
- Free Cash Flow
- +1.6%
Profitability
- Gross Margin
- 56.4%
- Operating Margin
- 29.2%
- Net Margin
- 16.9%
- ROE
- 10.2%
- ROIC
- 6.7%
Balance Sheet
- Debt/Equity
- 0.59
- Current Ratio
- 3.11
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.